Outline. Personal profile & research interests. Rheumatology research in Ireland. Current standing. Future plans
|
|
- Dwight Miller
- 8 years ago
- Views:
Transcription
1
2 Outline Personal profile & research interests Rheumatology research in Ireland Current standing Future plans
3 Personal profile 1983 MB Queens University ARUK Clinical Research Fellowship Genetics of TNF gene in RA Prof Sir Gordon Duff 1995 PhD ARUK Travelling Fellowship Stanford University, California Effects of TNF genetics on TNF production 1996 Senior Registrar Oxford Professor of Rheumatology University of Sheffield
4 Doctors are men who prescribe medicines of which they know little, to cure diseases of which they know less, in human beings of whom they know nothing Voltaire
5 5 4 TNF (ng/ml/106 cells)
6 Patient stratification: Predicting severity of RA in individual patients Therapeutic targeting: selecting the best drug for the patient personalised medicines
7 Assessing radiological damage in RA Radiological scoring Modified Larsen score 32 joints of hands & feet Score Larsen, A J Rheumatol 22:
8 Variability in radiological damage in RA Genetic of Rheumatoid Arthritis (GoRA) study 1,007 patients attending RHH Larsen 80 score Disease duration (yrs)
9 Severity of RA is highly variable Year RA diagnosed 1999 X-ray damage score
10 Biomarkers in rheumatoid arthritis A distinct biological or biologically derived indicator of a event, process or condition DNA SNPs Bone Alkaline Phosphatase Cartilage Hyaluronic acid, cartilage oligomeric protein, aggrecan Inflammation CRP, ESR Immune Rheumatoid Factor and anti-ccp Diagnostic/Prognostic/therapeutic response eg anti-ccp
11 P=0.04
12 Patient stratification: Predicting severity of RA in individual patients Therapeutic targeting: selecting the best drug for the patient personalised medicines
13 Oct 26th 2006 It got to the point where walking was agony, like walking barefoot on a stony beach The rheumatologist diagnosed aggressive rheumatoid arthritis and said some of my joints had permanent damage. I was devastated, I was a fit 23-year-old one minute and next I was in pain, exhausted and could barely walk. There was no history of arthritis in my family, so I was stunned. Doctors first tried a number of different treatments but Stephanie suffered dreadful side-effects including vomiting and mouth ulcers. Finally they found an anti-tnf drug which caused only a mild rash, but brought a real improvement to her symptoms. The difference has been amazing, says Stephanie. Although it is not a cure, I cannot describe the major difference these drugs have made to my life. The good days now outnumber the bad days ten-fold and I am trying to put my life back together. Stephanie Phillips Stephanie is starting medical school next year and she hopes to become a rheumatologist.
14 Biological treatments for RA Improved Efficacy Good side effect profile Cost Non-response (~30%) Increasing numbers of biologicals TNF inhibitors x5 IL-1ra IL-6R antibody Rituximab (B cells) Abatacept (T cells) Therapeutic targeting
15 Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate (BRAGGSS) Aim - to identify biomarkers predictive of response to anti-tnf British Society for Rheumatology Biologics Register database used to identify suitable anti-tnf treated patients - Baseline and 6 month DAS score - DNA from >3,500 patients (retrospective) - Prospective study underway (>n=600) Anne Barton (Manchester) Ann Morgan (Leeds) John Isaacs (Newcastle) Gerry Wilson (Sheffield)
16
17 Rheumatology Research in Ireland Location Dublin Sheffield Liverpool Publications (n) Edinburgh Cardiff Belfast Glasgow 121
18 Research activity by country
19 Research plans Next 12 months Appointment of Professor in TCD (Immunology) Centre of Excellence in Rheumatology (Dublin) Patient centred studies in common rheumatic diseases across Dublin & Ireland Research Databases & biological samples
20 Developing an Arthritis Ireland Centre for Rheumatology Research Autoimmune rheumatology Crystal arthritis Osteoarthritis Clinical cohorts & biorepositories Genomics Transcriptomics Immunology Imaging (Ultrasound/MRI) Statistics Insights into Pathogenic mechanisms Identification of novel therapeutic targets Patient stratification and therapeutic targeting
21 Developing a Dublin Centre for Rheumatology Develop local, national, international research networks Develop research programmes in rheumatic diseases Research funding SFI, HRB, WT, EU, Industrial EULAR Centre of Excellence Develop training pathways and opportunities Patients
22 ?
Improvement in Quality of Life of Rheumatoid Arthritis Patients on Biologic Therapy
Improvement in Quality of Life of Rheumatoid Arthritis Patients on Biologic Therapy R Adams 1, Ct Ng 2, A Gibbs 2, L Tilson 1, D Veale 2, B Bresnihan 2, O FitzGerald 2, M Barry 1 1. National Centre for
More informationLinking biobanks to registries: Why and how? Anne Barton
Linking biobanks to registries: Why and how? Anne Barton Biobanks why should we collect samples? Anti-TNF treatment in RA Cost approx. 8,000/person/year 30-40% RA patients do not respond Rare, serious
More informationArthritis Research UK Epidemiology Unit
Arthritis Research UK Epidemiology Unit Qualitative research proposal to explore factors influencing acceptable risk thresholds used to recommend particular treatment options for rheumatoid arthritis.
More informationUnderstanding Rheumatoid Arthritis
Understanding Rheumatoid Arthritis Understanding Rheumatoid Arthritis What Is Rheumatoid Arthritis? 1,2 Rheumatoid arthritis (RA) is a chronic autoimmune disease. It causes joints to swell and can result
More informationMedia Release. Basel, 11 June 2009. RA patients with enhanced response identified
Media Release Basel, 11 June 2009 New data demonstrate the ability of MabThera to reduce the progression of joint damage when used as a first-line biologic treatment in rheumatoid arthritis RA patients
More informationCurrent Rheumatoid Arthritis Treatment Options: Update for Managed Care and Specialty Pharmacists
Current Rheumatoid Arthritis Treatment Options: Update for Managed Care and Specialty Pharmacists 1. Which of the following matches of biologic targets that contribute to rheumatoid arthritis (RA) and
More informationRheumatoid Arthritis www.arthritis.org.nz
Rheumatoid Arthritis www.arthritis.org.nz Did you know? RA is the second most common form of arthritis Approximately 40,000 New Zealanders have RA RA can occur at any age, but most often appears between
More informationRheumatology Labs for Primary Care Providers. Robert Monger, M.D., F.A.C.P. 2015 Frontiers in Medicine
Rheumatology Labs for Primary Care Providers Robert Monger, M.D., F.A.C.P. 2015 Frontiers in Medicine Objectives Review the Indications for and Interpretation of lab testing for the following diseases:
More informationImmune modulation in rheumatology. Geoff McColl University of Melbourne/Australian Rheumatology Association
Immune modulation in rheumatology Geoff McColl University of Melbourne/Australian Rheumatology Association A traditional start to a presentation on biological agents in rheumatic disease is Plasma cell
More informationDeveloping a National Audit for Rheumatoid and Early Inflammatory Arthritis Ian Rowe
Developing a National Audit for Rheumatoid and Early Inflammatory Arthritis Ian Rowe Chair Clinical Affairs Committee, BSR Outline The British Society for Rheumatology Challenges in improving patient outcomes
More informationRheumatoid Arthritis
Rheumatoid Arthritis While rheumatoid arthritis (RA) has long been feared as one of the most disabling types of arthritis, the outlook has dramatically improved for many newly diagnosed patients. Certainly
More informationRheumatoid Arthritis. Disease RA Final.indd 2 15. 6. 10. 11:23
Rheumatoid Arthritis Disease RA Final.indd 2 15. 6. 10. 11:23 Understanding what to expect can help you prepare for your transition into treatment. Rheumatoid Arthritis What You Need To Know About Rheumatoid
More informationA Survey of Barriers to Treatment Access in Rheumatoid Arthritis. Country Annex Report: UK
A Survey of Barriers to Treatment Access in Rheumatoid Arthritis Country Annex Report: UK October 2009 1 Interviews In the UK, five rheumatologists and one patient representative were interviewed. The
More informationAm I likely to develop. rheumatoid Arthritis? A guide for people with joint symptoms
Am I likely to develop Rheumatoid rheumatoid Arthritis? arthritis? A guide for people with joint symptoms At a glance Rheumatoid arthritis (RA) is a common disease that causes painful and swollen joints,
More informationDo I need a physician referral? Yes, we see patients on referral from a health care provider.
FAQS FOR OFFICE POLICIES How do I get an appointment? New appointments are made by physician referral only. Your referring health care provided will call for the appointment for you. What do I need to
More informationA Genetic Analysis of Rheumatoid Arthritis
A Genetic Analysis of Rheumatoid Arthritis Introduction to Rheumatoid Arthritis: Classification and Diagnosis Rheumatoid arthritis is a chronic inflammatory disorder that affects mainly synovial joints.
More informationHow does Vectra DA measure my RA disease activity? What is Vectra DA? The more you and your doctor know about your RA, the better you can manage it
KNOW YOUR RA SCORE 65 58 50 42 40 35 29 21 15 The advanced blood test that helps you and your doctor better understand your rheumatoid arthritis (RA) disease activity with a single score 1 What is Vectra
More informationRheumatoid Arthritis www.arthritis.org.nz
Rheumatoid Arthritis www.arthritis.org.nz Did you know? Rheumatoid arthritis (RA) is the third most common form of arthritis Approximately 40,000 New Zealanders have RA RA can occur at any age, but most
More informationBiologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate (BRAGGSS): DATA AND SAMPLE ACCESS AND OWNERSHIP POLICY February 2007
Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate (BRAGGSS): DATA AND SAMPLE ACCESS AND OWNERSHIP POLICY February 2007 1. Summary This paper covers the procedures that should be followed
More informationBEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE (JPC)
BEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE (JPC) September 2014 Review date: September 2017 Bulletin 203: Tocilizumab (subcutaneous) in combination with methotrexate or as monotherapy for the treatment
More informationLatvian Early Intervention Concept development
Latvian Early Intervention Concept development Professor Daina Andersone, Medical Faculty of Latvian University Fit for Work Medical team leader in Latvia Latvian Presidency of the EU Council Healthcare
More informationThe Burden of Rheumatoid
The Burden of Rheumatoid Arthritis (RA) and Patient Access to Treatment by prof. Bengt Jönsson, DR. Gisela Kobelt and PROF. Josef Smolen summary of key findings Table of contents Introduction Introduction
More informationDOCTOR DISCUSSION GUIDE FOR RHEUMATOID ARTHRITIS
DOCTOR DISCUSSION GUIDE FOR RHEUMATOID ARTHRITIS Talking your Doctor About Rheumatoid Arthritis Preparing for your Doctor s Appointment Early and aggressive treatment can help you forestall the joint damage
More informationCan Rheumatoid Arthritis treatment ever be stopped?
Can Rheumatoid Arthritis treatment ever be stopped? Robert L. DiGiovanni, DO, FACOI Program Director Largo Medical Center Rheumatology Fellowship robdsimc@tampabay.rr.com Do not pour strange medicines
More informationRheumatoid Arthritis Information
Rheumatoid Arthritis Information Definition Rheumatoid arthritis (RA) is a long-term disease that leads to inflammation of the joints and surrounding tissues. It can also affect other organs. Alternative
More informationSymptoms ongoing for 6/12, initially intermittent in nature.
Rheumatoid Arthritis Case Study INTRODUCTION Each student will have watched the relevant MDT member carrying out their initial assessment on the same newly diagnosed Rheumatoid Arthritis patient. Videos
More informationInformation on Rheumatoid Arthritis
Information on Rheumatoid Arthritis Table of Contents About Rheumatoid Arthritis 1 Definition 1 Signs and symptoms 1 Causes 1 Risk factors 1 Test and diagnosis 2 Treatment options 2 Lifestyle 3 References
More informationArthritis and Rheumatology. Antoni Chan MBChB, FRCP, PhD Consultant Rheumatologist Royal Berkshire NHS Foundation Trust
Antoni Chan MBChB, FRCP, PhD Consultant Rheumatologist Royal Berkshire NHS Foundation Trust Rheumatology Investigation, Diagnosis, Treatment The challenge 8 billion a year in cost 700,000 people suffering
More informationUnderstanding and improving communications between people with rheumatoid arthritis and their healthcare professionals. RCUKCOMM00116w February 2014
Understanding and improving communications between people with rheumatoid arthritis and their healthcare professionals RCUKCOMM00116w February 2014 This project has been funded by Roche Products Ltd &
More informationRheumatoid Arthritis
Rheumatoid Arthritis Carole Callaghan Principal Pharmacist NHS Lothian Aim To update pharmacists on the current management of rheumatoid arthritis and explore ways to implement pharmaceutical care for
More informationRoche s RoACTEMRA improved rheumatoid arthritis signs and symptoms significantly more than adalimumab as single-agent therapy
Media Release Basel, 6 June 2012 Roche s RoACTEMRA improved rheumatoid arthritis signs and symptoms significantly more than adalimumab as single-agent therapy Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced
More informationThe Most Common Autoimmune Disease: Rheumatoid Arthritis. Bonita S. Libman, M.D.
The Most Common Autoimmune Disease: Rheumatoid Arthritis Bonita S. Libman, M.D. Disclosures Two googled comics The Normal Immune System Network of cells and proteins that work together Goal: protect against
More informationNew Evidence reports on presentations given at EULAR 2012. Rituximab for the Treatment of Rheumatoid Arthritis
New Evidence reports on presentations given at EULAR 2012 Rituximab for the Treatment of Rheumatoid Arthritis Report on EULAR 2012 presentations Long-term safety of rituximab: 10-year follow-up in the
More informationEvidence-based Management of Rheumatoid Arthritis (2009)
CPLD reviews its distance learning programmes every twelve months to ensure currency. This update has been produced by an expert and should be read in conjunction with the Evidencebased Management of distance
More informationClinically Actionable Biomarkers in Rheumatoid Arthritis
Clinically Actionable Biomarkers in Rheumatoid Arthritis PepTalk January 6, 2009 William Robinson, MD, PhD Stanford University School of Medicine VA Palo Alto Health Care System T cell mediated Autoimmune
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Health Technology Appraisal
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Health Technology Appraisal Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure
More informationMethotrexate (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023
Brochure More information from http://www.researchandmarkets.com/reports/3128342/ Methotrexate (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Description: Methotrexate (Rheumatoid Arthritis)
More informationInfl ectra for rheumatoid arthritis
Infl ectra for rheumatoid arthritis Some important information to get you started with your treatment This booklet is intended only for use by patients who have been prescribed Inflectra. Introduction
More informationThe National Centre for Biomedical Engineering Science
The How this Integrated Technology Platform has impacted the development of R&D Clusters in Galway Jacinta Thornton, PhD Executive Manager, NCBES National Centre for Biomedical Engineering g Science Mission
More informationBiologic Treatments for Rheumatoid Arthritis
Biologic Treatments Rheumatoid Arthritis (also known as cytokine inhibitors, TNF inhibitors, IL 1 inhibitor, or Biologic Response Modifiers) Description Biologics are new class of drugs that have been
More informationPatient Information Leaflet
Patient Information Leaflet METHOTREXATE We hope this fact sheet will provide you with some information about Methotrexate and answer some of the questions you may have. Methotrexate is available in tablet
More informationRheumatoid Arthritis: Symptoms, Causes, and Treatments of Rheumatoid Foot and Ankle
Rheumatoid arthritis is the most common form of inflammatory arthritis, affecting about two to three million Americans. Rheumatoid arthritis is a symmetric disease, meaning that it will usually involve
More informationRheumatology. Rheumatoid Arthritis
Rheumatology Rheumatoid Arthritis The Rheumatology service specialises in the diagnosis and treatment of diseases affecting the musculoskeletal system. Other than providing inpatient and outpatient consultation,
More informationDr Sarah Levy Consultant Rheumatology Croydon University Hospital
Dr Sarah Levy Consultant Rheumatology Croydon University Hospital Contents Definition/ epidemiology Diagnosis Importance of early diagnosis/ treatment Guidelines Evidence based treatment protocol Current
More informationTAKING CARE OF YOUR RHEUMATOID ARTHRITIS
TAKING CARE OF YOUR RHEUMATOID ARTHRITIS RHEUMATOID ARTHRITIS (RA) FAST FACTS What is Rheumatoid Arthritis? Rheumatoid arthritis (RA) is a chronic disease that can affect your ability to function and be
More informationPolymyalgia Rheumatica www.arthritis.org.nz
Polymyalgia Rheumatica www.arthritis.org.nz Did you know? Arthritis affects one in six New Zealanders over the age of 15 years. Polymyalgia rheumatica is a common rheumatic condition. It affects more women
More informationRheumatology. Arthritis
Rheumatology Arthritis The Rheumatology service specialises in the diagnosis and treatment of diseases affecting the musculoskeletal system. Other than providing inpatient and outpatient consultation,
More informationSYNOPSIS. 2-Year (0.5 DB + 1.5 OL) Addendum to Clinical Study Report
Name of Sponsor/Company: Bristol-Myers Squibb Name of Finished Product: Abatacept () Name of Active Ingredient: Abatacept () Individual Study Table Referring to the Dossier (For National Authority Use
More informationREFERENCE CODE GDHC503DFR PUBLICAT ION DATE DECEMBER 2014 METHOTREXATE (RHEUMATOID ARTHRITIS) - FORECAST AND MARKET ANALYSIS TO 2023
REFERENCE CODE GDHC503DFR PUBLICAT ION DATE DECEMBER 2014 METHOTREXATE (RHEUMATOID ARTHRITIS) - Executive Summary The table below provides the key metrics for Methotrexate in the 10MM (US, France, Germany,
More informationARTHRITIS INTRODUCTION
ARTHRITIS INTRODUCTION Arthritis is the most common disease affecting the joints. There are various forms of arthritis but the two that are the most common are osteoarthritis (OA), and rheumatoid arthritis
More informationPredictors of Physical Therapy Use in Patients with Rheumatoid Arthritis
Predictors of Physical Therapy Use in Patients with Rheumatoid Arthritis Maura Iversen,, PT, DPT, SD, MPH 1,2,3 Ritu Chhabriya,, MSPT 4 Nancy Shadick, MD 2,3 1 Department of Physical Therapy, Northeastern
More informationShared care protocol for the management of patients with Rheumatoid Arthritis treated with disease modifying antirheumatic drugs (DMARDs)
Tameside Hospital NHS Foundation Trust and NHS Tameside and Glossop Shared care protocol for the management of patients with Rheumatoid Arthritis treated with disease modifying antirheumatic drugs (DMARDs)
More informationANTIBODIES AGAINST CITRULLINATED PEPTIDES IN EARLY RHEUMATOID ARTHRITIS: DIAGNOSTIC AND PROGNOSTIC SIGNIFICANCE
ANTIBODIES AGAINST CITRULLINATED PEPTIDES IN EARLY RHEUMATOID ARTHRITIS: DIAGNOSTIC AND PROGNOSTIC SIGNIFICANCE Principal investigators: Dr Raimon Sanmartí Sala Hospital Clínic i Provincial de Barcelona
More informationHow will we prevent rheumatoid arthritis? Kevin Deane, MD/PhD Division of Rheumatology University of Colorado
How will we prevent rheumatoid arthritis? Kevin Deane, MD/PhD Division of Rheumatology University of Colorado Outline 1) Brief overview of natural history of RA and how current understanding of disease
More informationarthritis.org Rheumatoid Arthritis Understanding Symptoms, Diagnosis and Treatments
arthritis.org Rheumatoid Arthritis Understanding Symptoms, Diagnosis and Treatments About Rheumatoid Arthritis What Is Rheumatoid Arthritis? Arthritis is a general term for inflammation of the joints.
More information(Intro to Arthritis with a. Arthritis) Manager of Education & Services for the Vancouver Island Region of The Arthritis Society
Arthritis 101 (Intro to Arthritis with a Focus on Rheumatoid Arthritis) by Cari Taylor by Cari Taylor Manager of Education & Services for the Vancouver Island Region of The Arthritis Society What You Will
More informationDAS28 criteria for initiation of biologics in early RA: a clinician s view. Dr Patrick Kiely St George s Healthcare NHS Trust, London
DAS28 criteria for initiation of biologics in early RA: a clinician s view Dr Patrick Kiely St George s Healthcare NHS Trust, London History: NICE (E&W) guidelines for starting anti-tnf agents April 2001
More informationRHEUMATOID ARTHRITIS: PRIMARILY AN AUTOIMMUNE DISEASE JOHNATHON DUFTON, MD
RHEUMATOID ARTHRITIS: PRIMARILY AN AUTOIMMUNE DISEASE JOHNATHON DUFTON, MD RHEUMATOID ARTHRITIS: PRIMARILY AN AUTOIMMUNE DISEASE ACTIVITY DESCRIPTION Rheumatoid arthritis (RA) is an inflammatory type of
More informationRheumatoid arthritis inadults
Understanding NICE guidance Information for people who use NHS services Rheumatoid arthritis inadults NICE clinical guidelines advise the NHS on caring for people with specific conditions or diseases and
More informationMaster Thesis in Medicine
RISK OF INFECTIONS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOCILIZUMAB IN CLINICAL PRACTICE Master Thesis in Medicine Joyce Åkerlund Supervisor: Catharina Lindholm, MD, PhD, Associate Professor Department
More informationIt is most common between the ages of 40 and 70, but can affect people of any age.
Rheumatoid arthritis Introduction Rheumatoid arthritis is a condition that causes pain and swelling in the joints. Hands, feet and wrists are commonly affected, but it can also damage other parts of the
More informationArthritis: An Overview. Michael McKee, MD, MPH February 23, 2012
Arthritis: An Overview Michael McKee, MD, MPH February 23, 2012 Supporters Deaf Health Talks is possible through the support of: Rochester Recreation Club for the Deaf ( REAP ) Deaf Health Community Committee
More informationPsoriatic Arthritis www.arthritis.org.nz
Psoriatic Arthritis www.arthritis.org.nz Did you know? Arthritis affects one in six New Zealanders over the age of 15 years. Psoriatic arthritis usually appears in people between the ages of 30 to 50.
More informationTreat to Target Approach in Rheumatoid Arthritis: UK perspective. Dr Deirdre Shawe, North Hampshire Hospital, Basingstoke, UK
Treat to Target Approach in Rheumatoid Arthritis: UK perspective Dr Deirdre Shawe, North Hampshire Hospital, Basingstoke, UK What is the target? To achieve remission or low disease activity in Rheumatoid
More informationEffectiveness and Drug Adherence in Rheumatoid Arthritis Patients on Biologic Monotherapy: A prospective observational study in Southern Sweden
Effectiveness and Drug Adherence in Rheumatoid Arthritis Patients on Biologic Monotherapy: A prospective observational study in Southern Sweden Collaborators: Primary investigators Dr Lars Erik Kristensen,
More informationTherapeutic Class Overview : Psoriasis Plaque Psoriasis & Psoriatic Arthritis - Novel Oral Drugs And Biologics To Change Future Treatment Paradigm
Brochure More information from http://www.researchandmarkets.com/reports/2763286/ Therapeutic Class Overview : Psoriasis Plaque Psoriasis & Psoriatic Arthritis - Novel Oral Drugs And Biologics To Change
More informationBig Data for Population Health and Personalised Medicine through EMR Linkages
Big Data for Population Health and Personalised Medicine through EMR Linkages Zheng-Ming CHEN Professor of Epidemiology Nuffield Dept. of Population Health, University of Oxford Big Data for Health Policy
More informationCoxib s have taught us a lesson to explore more diligently the molecular and cellular pathways of inflammation
Coxib s have taught us a lesson to explore more diligently the molecular and cellular pathways of inflammation Steffen Gay Arthritis linked to cardiovascular disease CV Death Osteoarthritis CHF Rheumatoid
More informationArthritis in Children: Juvenile Rheumatoid Arthritis By Kerry V. Cooke
Reading Comprehension Read the following essay on juvenile rheumatoid arthritis. Then use the information in the text to answer the questions that follow. Arthritis in Children: Juvenile Rheumatoid Arthritis
More informationRheumatoid Arthritis
Rheumatoid Arthritis Rheumatoid arthritis (RA) is an autoimmune disease that causes chronic inflammation of the joints. Autoimmune diseases are illnesses that occur when the body's tissues are mistakenly
More informationABOUT RHEUMATOID ARTHRITIS
MEDIA BACKGROUNDER ABOUT RHEUMATOID ARTHRITIS Rheumatoid arthritis (RA) is a type of arthritis (chronic inflammatory polyarthritis) that typically affects hands and feet, although any joint in the body
More informationPrognostic factors in rheumatoid arthritis
Prognostic factors in rheumatoid arthritis Thesis Éva Palkonyai M.D. Semmelweis University, Budapest School of Ph.D. Studies Supervisor: Péter Gergely MD, D.Sci Budapest 2006. 1 Contents 1. Introduction
More informationEarly identification and treatment - the Norwegian perspective. Till Uhlig Dept of Rheumatology Diakonhjemmet Hospital Oslo, Norway
Early identification and treatment - the Norwegian perspective Till Uhlig Dept of Rheumatology Diakonhjemmet Hospital Oslo, Norway Oslo Rheumatoid Arthritis Registry (ORAR) Very early Arthritis Clinic
More informationContents. From the Directors. Patient-Centered Outcomes
Fall / Winter 2006 BRASS Contents Patient-Centered Outcomes: Communication between you and your rheumatologist can make a difference in your health: cover and page 2 Two New RA Drugs, Abatacept and Rituximab:
More informationNew Investigators. 2012 report
New Investigators 2012 report Summary Cancer Research UK has a strong portfolio of fellowships to support new researchers at the start of their independent careers. We currently support our new investigators
More informationTreating Rheumatoid Arthritis to Target : the patient version of the international recommendations
Treating Rheumatoid Arthritis to Target : the patient version of the international recommendations Data presented from the publication: M. de Wit, et al. Ann Rheum Dis. 2011;70:891-5. Epub Apr 7, 2011.
More informationRheumatoid arthritis: an overview. Christine Pham MD
Rheumatoid arthritis: an overview Christine Pham MD RA prevalence Chronic inflammatory disease affecting approximately 0.5 1% of the general population Prevalence is higher in North America (approaching
More informationOriginal paper Reumatologia 2015; 53, 4: 200 206 DOI: 10.5114/reum.2015.53997
Original paper Reumatologia 05; 53, 4: 00 06 DOI: 0.54/reum.05.53997 Rheumatoid arthritis treatment with TNF inhibitors and alternative procedures in case of its failure results of the Polish survey in
More informationPROVEN NON-INVASIVE TREATMENT FOR RHEUMATOID ARTHRITIS
PROVEN NON-INVASIVE TREATMENT FOR RHEUMATOID ARTHRITIS BIONICARE HAND SYSTEM Non-drug, non-invasive Adjunctive therapy For patients symptomatic despite current therapy For patients intolerant to drug
More informationOnce the immune system is triggered, cells migrate from the blood into the joints and produce substances that cause inflammation.
HealthExchange Points For Your Joints An Arthritis Talk Howard Epstein, MD Orthopaedic & Rheumatologic Institute Rheumatic & Immunologic Disease Cleveland Clinic Beachwood Family Health & Surgery Center
More informationRheumatic Diseases, Psoriasis, and Crohn s Disease
Rheumatic Diseases, Psoriasis, and Crohn s Disease What does this handout cover? This handout has information about rheumatic disease, psoriasis, and Crohn s disease. It also has information on how these
More informationAmrit pal S. Sandhu, M.D.
Amrit pal S. Sandhu, M.D. 2011 Myhre Place Silverdale, WA 98383 (360) 830-1610 PLEASE READ THIS CAREFULLY PRIOR TO YOUR FIRST ARTHRITIS CLINIC VISIT!!! ARTHRITIS/RHEUMATISM SERVICES Arthritis and Rheumatism
More informationThe management of rheumatoid arthritis
Medical management of rheumatoid arthritis Peter Jones Correspondence to: peter.jones@qehealth.co.nz The management of rheumatoid arthritis has changed in the last 10 years. Back then, a patient who awoke
More informationTACERA TOWARDS A CURE FOR EARLY RHEUMATOID ARTHRITIS
TACERA TOWARDS A CURE FOR EARLY RHEUMATOID ARTHRITIS The TACERA study; Towards A Cure for Early Rheumatoid Arthritis PROTOCOL TITLE: The TACERA study; a longitudinal observational study of patients with
More informationBIOM 255 - Firestein, Winter 2009. Rheumatoid arthritis. Page 1
Rheumatoid arthritis Page 1 Vascular events in RA Synovium in rheumatoid arthritis Non-extra articular RA Extra articular RA Turesson, et al. Ann Rheum Dis. 2007;66:60 Normal Rheumatoid Arthritis Major
More informationRHEUMATOID ARTHRITIS. Dr Bruce Kirkham Rheumatology Clinical Lead
RHEUMATOID ARTHRITIS Dr Bruce Kirkham Rheumatology Clinical Lead RHEUMATOID ARTHRITIS (RA) RA is a common disease: 0.8 per cent of the population RA more common in females: female to male ratio 3:1 RA
More informationYour Guide to. Rheumatoid Arthritis Medicines. We live with rheumatoid arthritis.
Your Guide to Rheumatoid Arthritis Medicines We live with rheumatoid arthritis. Your Guide to Rheumatoid Arthritis Medicines Chapter 1 - Page 4 What is rheumatoid arthritis (RA)? Chapter 2 - Page 6 What
More informationAssociation of HLA-DRB1 Haplotypes With Rheumatoid Arthritis Severity, Mortality, and Treatment Response
Research Original Investigation Association of HLA-DRB1 Haplotypes With Rheumatoid Arthritis Severity, Mortality, and Treatment Response SebastienViatte, MD, PhD; Darren Plant, PhD; Buhm Han, PhD; Bo Fu,
More informationDISEASE COURSE IN EARLY RHEUMATOID ARTHRITIS: AN OBSERVATIONAL STUDY
ORIGINAL ARTICLES DISEASE COURSE IN EARLY RHEUMATOID ARTHRITIS: AN OBSERVATIONAL STUDY Teodora Serban 1,2, Iulia Satulu 2, Oana Vutcanu 2, Mihaela Milicescu 1,2, Carina Mihai 1,2, Mihai Bojinca 1,2, Victor
More informationmy personal joint profile Your own personal profile of how rheumatoid arthritis is affecting your joints.
my personal joint profile Your own personal profile of how rheumatoid arthritis is affecting your joints. What you and your rheumatologist can learn from your joint profile. It seems like a simple question:
More informationLeflunomide Leflunomide
Drug information Leflunomide Leflunomide This leaflet provides information on leflunomide and will answer any questions you have about the treatment. Arthritis Research UK produce and print our booklets
More informationCLINICAL PSYCHOLOGISTS - applicants must have the following to be able to register:
f First Coht suppt application f Final Coht Bang University (Prifysgol Bang) (fmerly University of Wales, Bang / University College, Bang) Diploma in Clinical Psychology (aka Nth Wales In-Service Course)
More informationArthritis www.patientedu.org
written by Harvard Medical School Arthritis www.patientedu.org Arthritis is the most common chronic disease in the world, and it s the leading cause of disability in the United States. There are more than
More informationVectra DA Blood Test for Rheumatoid Arthritis. Original Policy Date January /2014
MP 2.04.81 Vectra DA Blood Test for Rheumatoid Arthritis Medical Policy Section 2.0 Original Policy Date January /2014 Last Review Status/Date 1/2014 Disclaimer Our medical policies are designed for informational
More informationRituximab. Drug information Rituximab. This leaflet provides information on rituximab and will answer any questions you have about the treatment.
Drug information Rituximab Rituximab This leaflet provides information on rituximab and will answer any questions you have about the treatment. Arthritis Research UK produce and print our booklets entirely
More informationX-Plain Rheumatoid Arthritis Reference Summary
X-Plain Rheumatoid Arthritis Reference Summary Introduction Rheumatoid arthritis is a fairly common joint disease that affects up to 2 million Americans. Rheumatoid arthritis is one of the most debilitating
More informationWelcome to. My plan for my life with
Welcome to My plan for my life with My details This book belongs to: If this book is found, please return it to: My diagnosis is: I also live with these medically diagnosed conditions: My NHS number is:
More informationEarly detection of breast cancer
Early detection of breast cancer Professor Denise Kendrick Division of Primary Care 1 5/26/2016 Average Number of New Cases Per Year and Age-Specific Incidence Rates per 100,000 Population Females, UK
More informationCOMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP)
The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 17 December 2003 CPMP/EWP/556/95 rev 1/Final COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP)
More informationSAP HANA Enabling Genome Analysis
SAP HANA Enabling Genome Analysis Joanna L. Kelley, PhD Postdoctoral Scholar, Stanford University Enakshi Singh, MSc HANA Product Management, SAP Labs LLC Outline Use cases Genomics review Challenges in
More information